Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and Torsade de Pointes

atazanavir sulfate has been researched along with Torsade de Pointes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ly, T; Ruiz, ME1

Other Studies

2 other study(ies) available for atazanavir sulfate and Torsade de Pointes

ArticleYear
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
    Prescrire international, 2009, Volume: 18, Issue:101

    Topics: Anti-HIV Agents; Anti-Retroviral Agents; Atazanavir Sulfate; Drug Approval; Drug Therapy, Combination; Europe; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Jaundice; Lopinavir; Oligopeptides; Pyridines; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Torsades de Pointes; Viral Load

2009
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Mar-15, Volume: 44, Issue:6

    Topics: Atazanavir Sulfate; Electrocardiography; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Long QT Syndrome; Middle Aged; Oligopeptides; Pyridines; Risk Assessment; Torsades de Pointes

2007